SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 260 participants.
Also called NCT03263117
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 260 participants
- Registry
-
NCT03263117
-
- Other papers using this trial's data
- Sedation vs General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke: The SEGA Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03263117. Randomized; single masking; primary purpose treatment. Start 2018-07-01 (actual); primary completion 2023-04-22 (actual). Results posted on 2024-09-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke
- Acronym
- SEGA
- Condition
- Stroke
- Intervention (Drug)
- Sedation
- Intervention (Drug)
- General Anesthesia (GA)
- Intervention (Procedure)
- Intra-arterial Thrombectomy
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Collaborator
- Stryker Neurovascular
Record details
- Record id
cardio:ct-nct03263117- Content hash
f36917e486c0caab8e07ca63a8c3cb82838542e57c2af20fb4dbc1a7d26be707